U.S. Flexible Endoscopic Surgery Robot Market Size & Share 2025 - 2034

U.S. Flexible Endoscopic Surgery Robot Market Size

The U.S. flexible endoscopic surgery robot market was valued at USD 326.4 million in 2024. The market is expected to reach from USD 367.6 million in 2025 to USD 1.3 billion in 2034, growing at a CAGR of 14.7% during the forecast period, according to the latest report published by Global Market Insights Inc. Rising demand for minimally invasive procedures and advancements in robotic precision and AI integration are driving market growth.

The flexible endoscopic surgery robot market in the U.S. provides hospitals, ambulatory surgical centers, and healthcare providers with advanced surgical solutions to perform minimally invasive procedures with increased precision, flexibility, and better outcomes. It includes flexible robotic systems, designed for gastrointestinal, urological, gynecological, and pulmonary surgeries, based on AI, imaging, and robotic assistance for diagnostic and therapeutic purposes.
 

Key players dominating the market include Intuitive Surgical, Medtronic, CMR Surgical, Asensus Surgical, and Medrobotics; these companies, through continuous innovation, strategic collaborations, extensive R&D investments, and geographic expansion, strengthen their position in the market to meet the growing demand for technology-driven, safe, and efficient minimally invasive surgeries across the U.S.
 

The market has increased from USD 230.8 million in 2021 and reached USD 289.1 million in 2023. The growth of the U.S. flexible endoscopic surgery robot market is primarily driven by the rising demand for minimally invasive surgical instrument that reduce patient trauma, shorten hospital stays, and improve recovery outcomes. Increasing adoption of flexible robotic systems in gastrointestinal, urological, gynecological, and pulmonary surgeries is fueled by their ability to offer superior dexterity, visualization, and precision compared to conventional endoscopic techniques.
 

Technological advancements, including integration of artificial intelligence (AI), 3D medical imaging devices, and real-time navigation, are significantly enhancing the accuracy and safety of complex surgical interventions. Moreover, growing prevalence of gastrointestinal and colorectal disorders, coupled with an aging population requiring advanced surgical care, is accelerating market expansion.
 

Major healthcare facilities across the U.S. are investing in robotic-assisted platforms to improve surgical efficiency and standardize complex procedures. Supportive reimbursement frameworks and FDA approvals for new robotic systems are further promoting adoption. In addition, key market players such as Intuitive Surgical, Medtronic, CMR Surgical, Asensus Surgical, and Medrobotics are continuously innovating and collaborating with hospitals to expand clinical applications and training programs. As healthcare providers increasingly prioritize precision, efficiency, and patient-centric outcomes, flexible endoscopic robotic technologies are emerging as a critical component of next-generation minimally invasive surgery in the U.S.
 

A flexible endoscopic surgery robot is a robotic-assisted medical device that enables surgeons to perform minimally invasive procedures with superior precision, flexibility, and control. It integrates advanced robotic arms, artificial intelligence (AI), and high-definition imaging technologies to navigate complex anatomical areas, enhancing surgical accuracy, minimizing complications, reducing recovery time, and improving overall patient outcomes.
 

U.S. Flexible Endoscopic Surgery Robot Market Trends

The key drivers of the market is the rising preference for minimally invasive and scar-less surgical procedures. Patients, healthcare providers, and surgeons are increasingly favoring procedures that reduce physical trauma, minimize post-operative pain, shorten hospital stays, and accelerate recovery times.
 

• Unlike traditional open surgeries, minimally invasive techniques rely on small incisions, which significantly lower the risk of complications such as infections and excessive bleeding. This shift in patient and provider preference is driving hospitals and ambulatory surgical centers to adopt advanced robotic-assisted endoscopic systems.
   
• Flexible endoscopic surgery robots are particularly suited for complex procedures in the gastrointestinal, urological, gynecological, and pulmonary domains, where precision, dexterity, and access to challenging anatomical areas are critical.
   
• These robotic systems enhance surgeons’ capabilities by providing high-definition imaging, articulating robotic arms, and AI-assisted navigation, allowing for precise tissue manipulation and improved clinical outcomes. The emphasis on scar-less procedures not only improves cosmetic results but also contributes to better patient satisfaction and overall quality of care.
   
• Additionally, the trend toward outpatient and same-day surgical procedures aligns with the demand for minimally invasive surgeries. Patients increasingly prefer treatments that allow faster return to daily activities and reduce overall healthcare costs. Hospitals, in response, are investing in robotic technologies that support efficient, safe, and precise procedures, further fueling market growth.
   
• Moreover, regulatory approvals, insurance reimbursements, and clinical evidence supporting minimally invasive robotic surgeries are reinforcing their adoption across the U.S. healthcare system.
   
• As awareness of the benefits of scar-less procedures continues to grow, the demand for flexible endoscopic surgery robots is expected to increase, positioning the U.S. market for significant expansion over the forecast period.
   
• This trend underscores the critical role of patient-centric care and technological innovation in shaping the future of the market.
   

U.S. Flexible Endoscopic Surgery Robot Market Analysis

Based on the category, the U.S. flexible endoscopic surgery robot market is segmented into therapeutic and diagnostic. The therapeutic segment has asserted its dominance in the market by securing a significant market share of 60.4% in 2024, fueled by increasing adoption of minimally invasive procedures, enhanced precision and control, and rising demand for performing complex surgical interventions. The segment is expected to exceed USD 790.9 million by 2034, growing at a CAGR of 15.1% during the forecast period.
 

On the other hand, the diagnostic segment is expected to grow with a CAGR of 14.1%. The growth of this segment is driven by expanding screening programs, advancements in visualization technologies, and early disease detection enabled by robotic-assisted endoscopic procedures.
 

• The therapeutic segment dominates the market, driven primarily by the increasing adoption of minimally invasive procedures that offer faster recovery, reduced complications, and improved patient outcomes. Hospitals and ambulatory surgical centers are increasingly investing in robotic-assisted platforms for complex gastrointestinal, urological, gynecological, and pulmonary surgeries, where precision, dexterity, and access to difficult anatomical areas are critical.
   
• Advanced robotic systems provide enhanced control, high-definition imaging, and AI-assisted guidance, enabling surgeons to perform intricate interventions with greater accuracy. Rising demand for scar-less procedures, coupled with a growing prevalence of gastrointestinal and colorectal disorders, further fuels the segment’s expansion.
   
• Additionally, supportive reimbursement policies and clinical evidence demonstrating improved surgical outcomes encourage healthcare providers to adopt therapeutic robotic procedures.
   
• Strategic collaborations and R&D investments by key players such as Intuitive Surgical, Medtronic, and CMR Surgical are also accelerating innovations in therapeutic robotic systems, strengthening the segment’s growth trajectory over the forecast period.
   
• The diagnostic segment held a revenue of USD 129.2 million in 2024, with projections indicating a steady expansion at 14.1% CAGR from 2025 to 2034. The segment is witnessing significant growth due to the increasing emphasis on early disease detection and preventive care.
   
• Expanding screening programs for gastrointestinal, pulmonary, and urological disorders are driving the demand for robotic-assisted endoscopic systems that offer superior visualization and maneuverability. Advanced imaging technologies, including high-definition cameras, 3D imaging, and AI-assisted navigation, enhance the accuracy of diagnostic procedures, enabling clinicians to detect abnormalities at early stages.
   
• Minimally invasive diagnostic procedures are preferred by patients as they reduce procedural risks, discomfort, and recovery time, further boosting adoption. The integration of robotics in diagnostics allows for precise biopsy collection, thorough tissue examination, and improved procedural efficiency.
   
• Moreover, rising awareness among healthcare providers regarding the benefits of robotic-assisted diagnostics, coupled with ongoing technological innovations and strategic collaborations by market leaders such as Medtronic, Intuitive Surgical, and Asensus Surgical, is accelerating segment growth during the forecast period.
   

Based on application, the U.S. flexible endoscopic surgery robot market is classified into urology, respiratory applications, gastrointestinal applications, and other applications. The urology segment dominated the market with a revenue share of 44.6% in 2024 and is expected to reach USD 572.9 million within the forecast period.
 

• The urology segment leads in the U.S. flexible endoscopic surgery robot market due to a rise in the prevalence of urological disorders such as prostate cancer, kidney stones, and benign prostatic hyperplasia. Awareness among patients and regular programs for screening will lead to earlier diagnosis and intervention, thereby increasing demand for precision-guided robotic procedures.
   
• Flexible endoscopic robots offer enhanced dexterity, high-definition visualization, and minimally invasive access to complex urological anatomy, reducing surgical complications and improving post-operative recovery.
   
• Technological advancements, such as AI-assisted navigation, 3D imaging, and robotic articulation, allow urologists to perform delicate procedures with higher accuracy and efficiency. Additionally, patient preference for minimally invasive and scar-less surgeries is contributing to the segment’s growth.
   
• The respiratory applications segment held a revenue of USD 107.7 million in 2024, with projections indicating a steady expansion at 15.3% CAGR from 2025 to 2034. The respiratory applications segment is witnessing growth due to the rising incidence of chronic respiratory diseases, including lung cancer, chronic obstructive pulmonary disease (COPD), and airway obstructions.
   
• Flexible endoscopic surgery robots enable minimally invasive bronchoscopic procedures, providing precise access to complex pulmonary structures while minimizing trauma and post-operative complications. High-definition imaging, AI-assisted navigation, and articulating robotic arms improve accuracy in tumor resections, airway stenting, and diagnostic interventions.
   
• Increasing patient preference for minimally invasive and scar-less procedures is accelerating adoption within hospitals and specialty centers. Moreover, the segment benefits from advancements in robotic-assisted diagnostic and therapeutic technologies that reduce procedure time, enhance safety, and improve clinical outcomes.
   
• The gastrointestinal applications segment held a revenue of USD 58.1 million in 2024, with projections indicating a steady expansion at 13.4% CAGR from 2025 to 2034. The gastrointestinal (GI) applications segment is witnessing substantial growth due to the rising prevalence of gastrointestinal disorders, including colorectal cancer, inflammatory bowel disease (IBD), polyps, and other digestive tract conditions. Early diagnosis and minimally invasive treatment of these conditions are becoming increasingly important, driving the adoption of flexible endoscopic surgery robots.

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the U.S. flexible endoscopic surgery robot market is classified into hospital & clinics, ambulatory surgical centers, and other end users. The hospital & clinics segment dominated the market with a revenue share of 62.1% in 2024 and is expected to reach USD 824.3 million within the forecast period.
 

• The two largest segments account for over 89.5% of the total market value. The hospital & clinics segment dominates market, accounting for a significant revenue share due to its ability to handle complex and high-volume surgical procedures.
   
• Hospitals and clinics are increasingly adopting robotic-assisted systems to enhance surgical precision, reduce complications, and improve patient outcomes, particularly in gastrointestinal, urological, gynecological, and pulmonary surgeries. The growing demand for minimally invasive and scar-less procedures, coupled with technological advancements such as AI integration, high-definition imaging, and flexible robotic arms, is driving adoption in these settings.
   
• The ambulatory surgical centers segment held a revenue of USD 89.4 million in 2024, with projections indicating a steady expansion at 14.3% CAGR from 2025 to 2034. ASCs offer cost-effective, convenient, and efficient surgical care, attracting patients seeking reduced recovery times and lower treatment costs. Robotic-assisted endoscopic systems enhance precision, safety, and procedural efficiency in ASCs, allowing complex surgeries that were traditionally hospital-based to be performed in outpatient environments.
   
• The rising prevalence of gastrointestinal and urological disorders, coupled with patient preference for scar-less procedures, is driving adoption. Integration of AI, advanced imaging, and real-time navigation technologies ensures superior clinical outcomes, further boosting demand.

South Atlantic Flexible Endoscopic Surgery Robot Market
 

South Atlantic dominated the U.S. flexible endoscopic surgery robot market with the highest market share of 19.4% in 2024.
 

• The zone houses a high concentration of advanced healthcare facilities, including top-tier hospitals and specialized ambulatory surgical centers, which actively adopt cutting-edge robotic-assisted technologies to improve surgical outcomes and operational efficiency.
   
• The rising demand for minimally invasive and scar-less procedures among patients has further accelerated the deployment of flexible endoscopic surgical robots, particularly for gastrointestinal, urological, gynecological, and pulmonary surgeries.
   
• Technological advancements in robotic systems, such as AI integration, high-definition imaging, and flexible robotic arms, have enhanced the precision, safety, and efficiency of surgical interventions, making these systems highly attractive to healthcare providers in the South Atlantic.
   
• Additionally, the zone benefits from strong healthcare infrastructure, skilled surgeons, and robust training programs, which facilitate adoption and integration of complex robotic systems.
   
• Demographic factors, including a growing and aging population, are increasing the prevalence of gastrointestinal and respiratory disorders, thereby boosting demand for advanced surgical interventions.
   
• Favorable reimbursement policies, regulatory approvals, and support from key players such as Intuitive Surgical, Medtronic, CMR Surgical, Asensus Surgical, and Medrobotics are also supporting market growth.
   

Northeast Flexible Endoscopic Surgery Robot Market
 

Northeast flexible endoscopic surgery robot market accounted for USD 50 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The Northeast flexible endoscopic surgery robot market is witnessing significant growth, driven by several factors that are enhancing adoption across hospitals, ambulatory surgical centers, and specialty clinics. One of the key drivers is the rising demand for minimally invasive and scar-less surgical procedures.
   
• Patients in the zone increasingly prefer treatments that reduce post-operative pain, lower complication risks, and accelerate recovery, prompting healthcare providers to invest in advanced robotic-assisted systems.
   
• Technological advancements in flexible endoscopic robots, including integration of artificial intelligence (AI), high-definition imaging, and precision robotic arms, are enabling surgeons to perform complex gastrointestinal, urological, gynecological, and pulmonary procedures with enhanced accuracy and control.
   
• This capability is particularly valuable in the Northeast, where leading healthcare institutions and specialty clinics focus on delivering high-quality, patient-centric care.
   

Pacific Central Flexible Endoscopic Surgery Robot Market
 

The Pacific Central flexible endoscopic surgery robot market is anticipated to grow at a high CAGR of 15.5% during the analysis timeframe.
 

• The Pacific Central flexible endoscopic surgery robot market is poised for rapid growth, driven by the increasing adoption of minimally invasive surgical procedures and the rising demand for advanced robotic-assisted technologies. Growing awareness among healthcare providers and patients regarding the benefits of minimally invasive surgeries including reduced postoperative pain, shorter hospital stays, faster recovery, and lower risk of complications is fueling the demand for flexible endoscopic robotic systems in this zone.
   
• Hospitals and surgical centers are increasingly investing in these systems to enhance precision, dexterity, and control during complex procedures, particularly in gastrointestinal, urological, gynecological, and pulmonary surgeries.
   
• Technological advancements in robotic-assisted surgery, such as integration of artificial intelligence (AI), high-definition imaging, and real-time navigation systems, are further driving market adoption. These innovations allow surgeons to access difficult anatomical areas with enhanced accuracy, reducing procedural risks and improving clinical outcomes.
   

U.S. Flexible Endoscopic Surgery Robot Market Share

The market is highly competitive, with leading medical device manufacturers focusing on technological innovation, AI integration, and strategic collaborations to strengthen their market position. Rising demand for minimally invasive surgeries, increasing prevalence of gastrointestinal and colorectal disorders, and advancements in robotic-assisted systems are prompting companies to enhance surgical precision, flexibility, and efficiency. The market is further supported by the growing adoption of outpatient and same-day procedures across hospitals and ambulatory surgical centers.
 

Key players, including Intuitive Surgical, Medtronic, CMR Surgical, Asensus Surgical, and Medrobotics, collectively hold 52.2% of the U.S. market share, maintaining leadership through robust R&D pipelines, versatile product offerings, and partnerships with healthcare institutions for clinical integration and surgeon training. Their focus on improving haptic feedback, visualization, and semi-autonomous control is redefining procedural capabilities.
 

Emerging and niche companies are entering the market with compact, cost-effective flexible endoscopic robotic systems. Competitive differentiation now emphasizes miniaturization, enhanced maneuverability, and cross-specialty compatibility. As the market evolves, competition is expected to intensify, with a strong focus on AI-enabled navigation, real-time imaging, and interoperability within digital surgical ecosystems, positioning robotics as central to next-generation minimally invasive surgery in the U.S.
 

U.S. Flexible Endoscopic Surgery Robot Market Companies

A few of the prominent players operating in the U.S. flexible endoscopic surgery robot industry include:
 

• Asensus Surgical
• CMR Surgical
• Endo Tools Therapeutics
• GI View
• Intuitive Surgical
• Johnson & Johnson
• Medrobotics
• Medtronic
  
   
• Intuitive Surgical

Intuitive Surgical leads the U.S. flexible endoscopic surgery robot market with a share of 23.1% in 2024. Intuitive Surgical’s da Vinci SP system offers exceptional precision, 3D visualization, and single-port flexibility, enabling complex endoluminal and minimally invasive procedures. Its advanced robotic articulation, user-friendly surgeon console, and extensive clinical validation establish it as a global leader in flexible robotic-assisted surgery.
 

• Medtronic

Medtronic’s Hugo Robotic-Assisted Surgery (RAS) system is distinguished by its modular, portable design and integration with advanced visualization and data analytics. It delivers enhanced procedural flexibility, cost-effectiveness, and connectivity, making it a scalable and accessible solution in the market.
 

U.S. Flexible Endoscopic Surgery Robot Industry News:

• In May 2025, Olympus Corporation (Japan) received FDA 510(k) clearance for its EZ1500 series endoscopes, featuring Extended Depth of Field (EDOF) technology to improve visualization accuracy and diagnostic performance.
   
• In January 2025, KARL STORZ SE & Co. KG (Germany) completed the strategic acquisition of its long-term Swiss distributor, ANKLIN, to enhance its direct sales network in Switzerland. This acquisition strengthened customer engagement and optimized customized product and service delivery across the MedTech sector.
   
• In January 2024, Olympus Corporation (Japan) acquired Taewoong Medical Co., Ltd., a Korea-based medical device manufacturer. This acquisition expanded Olympus’s GI Endo Therapy product portfolio, enhanced its ability to deliver integrated clinical solutions, and advanced patient care standards through improved treatment outcomes.
   

The U.S. flexible endoscopic surgery robot market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Category

• Therapeutic
• Diagnostic

Market, By Application

• Urology
• Respiratory applications
• Gastrointestinal applications
• Other applications

Market, By End Use

• Hospital & clinics
• Ambulatory surgical centers
• Other end use

The above information is provided for the following zones:

• East North Central
• West South Central
• South Atlantic
• Northeast
• East South Central
• West North Central
• Pacific Central
• Mountain States